Diagnostic News and Research

RSS

New study tracks global colorectal cancer risk across 185 nations

Colorectal cancer has long been recognized as a major global health threat, but its burden is far from evenly distributed. Incidence and mortality rates vary dramatically across countries, and these differences are closely tied to socioeconomic development, dietary transitions, and the adoption of screening programs.

26 Aug 2026

Study tracks global patterns and socioeconomic inequalities in the burden of breast cancer

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death among women globally, accounting for nearly 2.3 million new cases and 670,000 deaths in 2022 alone.

26 Aug 2026

Scientists found a distinct gut microbiome pattern in people with symptomatic diverticular disease

A multicenter Japanese study found that symptomatic uncomplicated diverticular disease (SUDD) was associated with reduced gut microbial diversity, increased abundance of the Ruminococcus gnavus group, and depletion of Coprococcus and other butyrate-producing bacteria. Predictive microbiome analysis also identified enrichment of pathways linked to exopolysaccharide biosynthesis and the cell cycle, although the observational design means these associations cannot establish causality.

25 Aug 2026

NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers

Researchers at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center have received two grants from the National Institutes of Health (NIH) totaling $7.5 million to study whether exposure to per- and polyfluoroalkyl substances (PFAS), the synthetic compounds known as "forever chemicals," increases the risk of liver cancer and endometrial cancer.

25 Aug 2026

Novel blood-based method diagnoses Alzheimer’s disease with high accuracy

Alzheimer's disease (AD) accounts for 60–80% of global dementia cases, with its core pathological feature being the misfolding and aggregation of β-amyloid (Aβ) proteins in the brain.

25 Aug 2026

New lensless imaging method captures clearer images of moving objects

With the rapid development of smartphones, wearable devices, and portable medical diagnostic systems, increasingly stringent requirements have been placed on imaging systems: they are expected to provide clear images while remaining sufficiently compact and lightweight.

24 Aug 2026

Resistant malaria parasites become increasingly prevalent across Ethiopia

Researchers from the University of North Carolina at Chapel Hill's Institute for Global Health and Infectious Diseases, the Ethiopian Public Health Institute (EPHI), Brown University, the University of Notre Dame, and Ethiopia's Ministry of Health have found that malaria parasites carrying genetic markers associated with resistance to frontline antimalarial medicines and commonly used diagnostic tests are becoming increasingly prevalent across Ethiopia.

24 Aug 2026

Type 2 diabetes incidence increases 10-fold among American youth

Type 2 diabetes has traditionally been a disease that has developed mostly in middle-aged and older adults.

24 Aug 2026

Combined bio-histological score prevents overtreatment in liver transplant patients

Long‑term outcomes after liver transplantation remain hampered by complications linked to intensive immunosuppression—infections, cardiovascular events, kidney dysfunction, and metabolic disorders affect 10% to 40% of recipients.

24 Aug 2026

FDA clears innovative blood test for earlier Alzheimer's diagnosis

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer's disease.

21 Aug 2026

Only three of 1,357 FDA-cleared AI devices tested patient outcomes

Researchers found that among 1,357 FDA-cleared or approved AI/ML-enabled medical devices, only 34 were linked to registered clinical trials and just three had been evaluated for patient-centered outcomes. The study highlights major gaps in prospective testing, demographic representation, transparency, and evidence showing whether medical AI meaningfully improves patients’ health.

20 Aug 2026

New AI framework improves reliability of cancer pathology diagnosis

Cancer diagnoses directly affect treatment decisions and prognosis and can even have life-altering consequences.

20 Aug 2026

New review examines why tetanus remains a global health problem

Tetanus is often considered a disease of the past, remembered mainly through childhood vaccinations and warnings about rusty nails.

20 Aug 2026

The role of UV-Vis in biopharma QC

UV-Vis and fluorescence support faster QC of nucleic acid and protein concentration.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 20 Aug 2026

Review examines how medical imaging foundation models are moved toward clinical use

AI is already widely used for lesion detection, disease classification, and outcome prediction in medical imaging, but most systems remain narrowly designed for one task and depend heavily on expert-labelled data.

20 Aug 2026

Rapid test breakthrough could transform iron treatment worldwide

WEHI researchers have developed a blood test that can detect iron deficiency in minutes, overcoming key limitations of existing point-of-care diagnostics and potentially transforming how the condition is diagnosed and treated worldwide.

20 Aug 2026

Two distinct types of brain tissue work together to support cognition in older adults

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have found that two distinct types of brain tissue work together to support cognition in older adults, and that the health of the brain's short-range wiring may help soften the cognitive effects of gray matter loss.

20 Aug 2026

A single blood test could offer a glimpse of disease risk years in advance

Machine learning-derived cellular aging clocks mapped more than 7,000 plasma proteins to over 40 cell types, revealing marked differences in how individual cell populations age. These blood-based signatures were associated with future risks of Alzheimer’s disease, ALS, lung cancer, type 2 diabetes, and mortality across follow-up extending to 15 years.

19 Aug 2026

New genetic risk score uncovers hidden type 1 diabetes cases

Incorporating a genetic risk score into standard testing for a genetic form of diabetes which affects young people could identify hidden type 1 diabetes in around one in five patients with a negative genetic test.

19 Aug 2026